In non-small cell lung cancer, 6-shogaol inhibits AKT kinase activity by binding to the variable configuration site of Akt, thereby inducing cleavage of the apoptosis markers Caspase-3 and -7 [49]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.